EUVIMEDEUVIMED entdecken
Crossref

Predictors of Clinically Meaningful 1‐Year Health Status Improvements Following Endovascular or Surgical Revascularization: Insights From the BEST‐CLI Trial

Kim G Smolderen iD, Matthew Menard iD, Alik Farber iD, Mufti M Rahman iD, Kenneth Rosenfield iD, Michael Strong iD, Gheorghe Doros, Philip Goodney iD, Samir K Shah iD, Richard R Powell, Bjoern Suckow iD, Kim Houland und 5 weitere

Journal of the American Heart Association · 12.11.2026

DOI: 10.1161/jaha.125.043270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, online erschienen am 12.11.2026. Verfasst von Kim G Smolderen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cardiovascular Medicine Section, Vascular Medicine Outcomes (VAMOS) Program Yale School of Medicine New Haven CT USA. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite efforts to promote limb salvage in chronic limb‐threatening ischemia (CLTI), the factors associated with meaningful health status improvement after revascularization remain poorly understood. We examined predictors of meaningful 1‐year health status improvement following revascularization for CLTI.

Methods

We pooled endovascular and surgical arms from the BEST‐CLI (Best Endovascular Versus Best Surgical Therapy in Patients With CLTI) randomized controlled trial, including patients with CLTI (150 international sites, 2014–2019). Health status was assessed at baseline and 1 year using the peripheral artery disease‐specific Vascular Quality of Life questionnaire, the generic European Quality‐of‐Life 5 Dimensions, and the Short Form‐12 Physical and Mental Component Summary. Distribution‐based minimal clinically important difference thresholds were defined as 0.5 SD of baseline health status scores. Multivariable logistic regression identified predictors of no meaningful 1‐year improvement (same/worsened versus improved).

Results

Among 1017 patients (72.0% men, mean age 66.8±9.7 years), clinically meaningful improvements were reported by 76.5% for Vascular Quality of Life, 52.8% European Quality‐of‐Life 5 Dimensions, 56.7% for Short Form‐12 Physical Component Summary, and 42.1% for Short Form‐12 Mental Component Summary, regardless of revascularization type (surgical versus endovascular). Cardiometabolic risk factors and higher preprocedural health status increased the odds of no meaningful improvement. Revascularization type was not associated with Vascular Quality of Life improvement (odds ratio, 1.059 [95% CI, 0.91–1.23]; P =0.445; C statistic=0.77).

Conclusions

One‐year postrevascularization, over three‐fourths of individuals with CLTI perceived meaningful improvements in peripheral artery disease‐specific health, and over half improved overall physical health, regardless of procedure type. Cardiometabolic risk factors and higher preprocedural health status predicted 1‐year health status response. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT02060630

Schlagwörter

Stichwörter der Autor:innen

chronic limb‐threatening ischemiaoutcomesperipheral artery diseasequality of liferevascularization

Autor:innen und Institutionen

  • Department of Internal Medicine, Cardiovascular Medicine Section, Vascular Medicine Outcomes (VAMOS) Program Yale School of Medicine New Haven CT USA.
  • Department of Psychiatry, Psychology Section Yale School of Medicine New Haven CT USA.
  • Division of Vascular and Endovascular Surgery Brigham and Women's Hospital Boston MA USA.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Boston Medical Center Boston University Chobanian & Avedisian School of Medicine Boston MA USA.
  • Vascular Medicine and Intervention Massachusetts General Hospital Boston MA USA.
  • Biostatistics Department Boston University Boston MA USA.

ORCID-Profile: Kim G Smolderen, Matthew Menard, Alik Farber, Mufti M Rahman, Kenneth Rosenfield, Michael Strong, Philip Goodney, Samir K Shah, Bjoern Suckow, Gaëlle Romain, Jacob Cleman, Lindsey Scierka, Carlos Mena-Hurtado

Zitieren

APA

Smolderen, K. G., Menard, M., Farber, A., Rahman, M. M., Rosenfield, K., Strong, M., Doros, G., Goodney, P., Shah, S. K., Powell, R. R., Suckow, B., Houland, K., Siracuse, J., Romain, G., Cleman, J., Scierka, L., & Mena-Hurtado, C. (2026). Predictors of Clinically Meaningful 1‐Year Health Status Improvements Following Endovascular or Surgical Revascularization: Insights From the BEST‐CLI Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043270

Vancouver

Smolderen KG, Menard M, Farber A, Rahman MM, Rosenfield K, Strong M, et al. Predictors of Clinically Meaningful 1‐Year Health Status Improvements Following Endovascular or Surgical Revascularization: Insights From the BEST‐CLI Trial. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.043270

BibTeX
@article{Smolderen2026,
  author = {Smolderen, Kim G and Menard, Matthew and Farber, Alik and Rahman, Mufti M and Rosenfield, Kenneth and Strong, Michael and Doros, Gheorghe and Goodney, Philip and Shah, Samir K and Powell, Richard R and Suckow, Bjoern and Houland, Kim and Siracuse, Jeffrey and Romain, Gaëlle and Cleman, Jacob and Scierka, Lindsey and Mena-Hurtado, Carlos},
  title = {Predictors of Clinically Meaningful 1‐Year Health Status Improvements Following Endovascular or Surgical Revascularization: Insights From the BEST‐CLI Trial},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.043270}
}
Kostenlos starten →